HIV/AIDS Latest News Archive

Population Based Screening Crucial for Early Diagnosis/Treatment of STIs

Population Based Screening Crucial for Early Diagnosis/Treatment of STIs

Adopting suitable protocols for the early diagnosis of STIs is necessary to allow implementation of prevention measures that will safeguard public health.

Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

Temporary Decline in CD4 T-Cell Count After Hepatitis C Infection in PLWHIV

When hepatitis C is acquired in patients with HIV infection, CD4 T-cell counts temporarily decline after HCV seroconversion.

GlycA: A Novel Biomarker for CVD Risk in People With HIV

GlycA: A Novel Biomarker for CVD Risk in People With HIV

GlycA levels are higher in men with HIV compared with men with do not have HIV.

Not All Patients Prefer Delivery of STI/HIV Screening Results Via SMS

Not All Patients Prefer Delivery of STI/HIV Screening Results Via SMS

The delivery of STI/HIV screening results via SMS is well accepted but does not suit all patients.

Potential of HIV-Protective Drugs Administered Via Rectal Douches

Potential of HIV-Protective Drugs Administered Via Rectal Douches

Rectal douches could be a viable option to deliver HIV-protective drugs to men who practice receptive anal intercourse with other men.

Similar Measles Seroprevalence in People With and Without HIV

Similar Measles Seroprevalence in People With and Without HIV

Similar measles seroprevalence found across PLWHIV and people who do not have HIV, suggesting that PLWHIV do not need an additional dose of a measles vaccine.

Effect of HIV Pretreatment Drug Resistance on Virologic Outcomes

Effect of HIV Pretreatment Drug Resistance on Virologic Outcomes

Dual-class pretreatment drug resistance to first-line tenofovir/emtricitabine/efavirenz regiment may be associated with poorer virologic suppression.

Greater Temporal Summation of Pain in HIV With Chronic Pain

Greater Temporal Summation of Pain in HIV With Chronic Pain

Individuals with HIV and chronic pain may have greater temporal summation of pain compared with healthy individuals or those with HIV but no chronic pain.

Barriers to Prevention, Eradication of HIV Remain Despite Numerous Advances

Barriers to Prevention, Eradication of HIV Remain Despite Numerous Advances

Since the first clinical observation of HIV/AIDS in 1981, some 35.4 million people have died from AIDS-related illnesses.

Biologic Agents Used to Treat Patients With Psoriasis and HIV Infection

Biologic Agents Used to Treat Patients With Psoriasis and HIV Infection

Investigators evaluated the safety and effectiveness of conventional therapy with biologic immunosuppressive drugs to treat patients with HIV infection and psoriasis.

Elevated PCSK9 Levels Associated With Coronary Endothelial Dysfunction in PLWHIV

Elevated PCSK9 Levels Associated With Coronary Endothelial Dysfunction in PLWHIV

Increased proprotein convertase subtilisin/kexin type 9 (PCSK9) levels in people with HIV may be related to abnormal coronary endothelial function.

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

Lamivudine/Tenofovir Disoproxil Approved for the Treatment of HIV-1 Infection

The FDA has approved Temixys tablets for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in patients weighing ≥35kg.

Increased Risk of Meningococcal Disease in Men Who Have Sex With Men

Increased Risk of Meningococcal Disease in Men Who Have Sex With Men

Men who have sex with men have an increased risk of meningococcal disease, however, this risk is under-ascertained and improved surveillance is needed.

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

USPSTF Suggests Universal HIV Screening, PrEP for High-Risk Patients

Screening recommended for those ages 15 to 65 years, including pregnant women.

Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS

Increased Risk for First and Second Primary Cancers in Patients With HIV/AIDS

Increased cancer prevention, screening, and treatment are needed for people living with HIV both before and after an initial cancer diagnosis.

New Single-Vial Formulation of Tesamorelin Approved to Treat Excess HIV-Related VAT

New Single-Vial Formulation of Tesamorelin Approved to Treat Excess HIV-Related VAT

The new "F4" formulation is 4 times more concentrated than the version currently available on the market.

ART Initiated Pre-Pregnancy Lowers Hospitalization due to Infection in HIV-Exposed Infants

ART Initiated Pre-Pregnancy Lowers Hospitalization due to Infection in HIV-Exposed Infants

ART prior to becoming pregnant was linked with reduced risk for hospitalization because of infections in seronegative infants who are exposed to HIV.

Earlier Intervention May Have Lessened HIV Outbreak in Indiana

Earlier Intervention May Have Lessened HIV Outbreak in Indiana

Ensuring access to HIV services and harm-reduction interventions earlier could substantially reduce HIV incidence over the course of an actual outbreak.

High-Coverage Rollout of PReP Tied to Drop in HIV Diagnoses

High-Coverage Rollout of PReP Tied to Drop in HIV Diagnoses

A rapid, targeted, high-coverage rollout of HIV PrEP is associated with a decrease in HIV diagnoses among high-risk MSM.

Infant HIV Infection Ups Risk for Congenital CMV Infection

Infant HIV Infection Ups Risk for Congenital CMV Infection

HIV-exposed infants have high rates of congenital cytomegalovirus (cCMV) infection, and in utero HIV infection seems to be a major risk factor for cCMV.

Hispanics With HIV Face Higher Risk for HPV-Related Cancer

Hispanics With HIV Face Higher Risk for HPV-Related Cancer

But five-year survival was above 50 percent among HIV-infected Hispanics across HPV-related cancer types.

Advance Care Planning Lowers Symptoms in Teens With HIV

Advance Care Planning Lowers Symptoms in Teens With HIV

Family-centered pediatric advance care planning may result in fewer symptoms, less suffering.

Conflicting Findings of EBV-Biomarker Use in HIV-Related Lymphomas

Conflicting Findings of EBV-Biomarker Use in HIV-Related Lymphomas

Conflicting findings regarding the association between plasma Epstein-Barr virus load in PLWHIV and HIV-related lymphomas shows a need for assessment of who benefits from an optimal management of HIV infection and comorbidities.

Bioavailability of Coformulated ART Dispersible Tablet Comparable to Standard Formulation

Bioavailability of Coformulated ART Dispersible Tablet Comparable to Standard Formulation

A dispersible fixed-dose combination tablet formulation of abacavir/dolutegravir/lamivudine for the treatment of HIV-1 had higher bioavailability of dolutegravir compared to the nondispersible film-coated tablet.

470 Percent Increase in HIV PrEP Use in US, 2014 to 2016

470 Percent Increase in HIV PrEP Use in US, 2014 to 2016

From 2014 to 2016 there was an increase in the annual number of HIV preexposure prophylaxis (PrEP) users in the United States.

More Socioeconomic Challenges for Hispanic Women With HIV

More Socioeconomic Challenges for Hispanic Women With HIV

Hispanic/Latino women with HIV infection face more socioeconomic and language challenges than men, but the clinical outcomes are similar.

Viral Suppression in Children on ART Identified Via Quantitative HIV Antibody Levels

Viral Suppression in Children on ART Identified Via Quantitative HIV Antibody Levels

For children receiving , HIV-1-specific antibody levels can be useful markers for measuring viral suppression or for low residual cell-associated HIV-1 DNA levels.

Retention in HIV Care Drops Steadily After Prison Release

Retention in HIV Care Drops Steadily After Prison Release

For criminal justice-involved persons living with HIV, sustained retention in care decreases over time post-release.

Integrated Intervention Engages PLWHIV who Inject Drugs

Integrated Intervention Engages PLWHIV who Inject Drugs

A flexible, scalable intervention increases antiretroviral therapy and medication-assisted treatment use while reducing mortality in people who inject drugs.

Cryptococcal Meningitis May Be Linked With Higher Mortality in PLWHIV

Cryptococcal Meningitis May Be Linked With Higher Mortality in PLWHIV

Antiretroviral therapy initiation within 4 weeks of a cryptococcal meningitis diagnosis in PLWHIV appears to be associated with a higher mortality risk.

Psychosocial Factors Associated With Persistent Pain in HIV

Psychosocial Factors Associated With Persistent Pain in HIV

A recent meta-analysis and literature review found moderate evidence supporting an association between pain outcomes in people with HIV and several psychosocial factors.

Certain Patient Characteristics May Augment Tenofovir in Viral Suppression of HIV

Certain Patient Characteristics May Augment Tenofovir in Viral Suppression of HIV

Tenofovir diphosphate in dried blood spots was strongly associated with virologic suppression in those living with HIV on TDF-based therapies.

Abacavir Linked to Increased Risk for Cardiovascular Disease in PLWHIV

Abacavir Linked to Increased Risk for Cardiovascular Disease in PLWHIV

Exposure to abacavir is associated with an increased risk for cardiovascular disease in individuals infected with HIV.

Carotid Artery Atherosclerosis Is Associated With Mortality in Adults With HIV

Carotid Artery Atherosclerosis Is Associated With Mortality in Adults With HIV

Carotid artery plaque was predictive of mortality, with differences observed by sex and HIV serostatus.

HIV, TB Co-Infection Associated With Decreased Neurological Performance

HIV, TB Co-Infection Associated With Decreased Neurological Performance

Co-infection of HIV+ and tuberculosis (TB) may be associated with decreased neurological and neuropsychological functioning.

Metabolic Effects of Initiating Lopinavir/Ritonavir Treatment in Children

Metabolic Effects of Initiating Lopinavir/Ritonavir Treatment in Children

Lopinavir/ritonavir-based treatment may be associated with higher total cholesterol in young children.

Recipients of Popular Facial May Have Been Exposed to HIV, Hepatitis

Recipients of Popular Facial May Have Been Exposed to HIV, Hepatitis

Inspection at the VIP Spa in Albuquerque detected practices that might spread HIV or hepatitis B and C.

Checkpoint Blockade Demonstrates Antitumor Activity in HIV-Associated Kaposi Sarcoma

Checkpoint Blockade Demonstrates Antitumor Activity in HIV-Associated Kaposi Sarcoma

One patient achieved complete remission in the trial, while 5 other patients experienced partial remission.

Aptima and RealTime Assay Have High Concordance in Monitoring HIV Viral Load

Aptima and RealTime Assay Have High Concordance in Monitoring HIV Viral Load

The Aptima assay has 6-sigma performance, high concordance with the RealTime reference assay, and is user friendly and efficient, making it a good choice for laboratories that perform routine monitoring of HIV-1 viral loads.

Ibalizumab, a Treatment Option for Multidrug Resistant HIV-1 Infection

Ibalizumab, a Treatment Option for Multidrug Resistant HIV-1 Infection

Ibalizumab showed significant antiviral activity in patients with multidrug-resistant HIV-1 infection, advanced disease, and few other treatment options

FDA Approves Two New Oral Treatments for HIV-1 Infection

FDA Approves Two New Oral Treatments for HIV-1 Infection

Delstrigo is approved as a complete regimen whereas Pifeltro is to be administered in combination with other antiretrovirals.

Behavioral Intervention Reduces HIV Transmission Risk in Young Transgender Women

Behavioral Intervention Reduces HIV Transmission Risk in Young Transgender Women

A group-based behavioral intervention reduced the sexual risk for HIV infection and transmission by nearly 40% in young transgender women.

Patient Navigation Associated With Positive Outcomes in HIV

Patient Navigation Associated With Positive Outcomes in HIV

Patient navigation may be considered an effective strategy to enhance engagement and continuation in disease treatment among people with HIV.

Smartphone App Can Help Improve Outcomes in Patients With HIV

Smartphone App Can Help Improve Outcomes in Patients With HIV

Improvements seen in retention in care, CD4 counts, and viral suppression.

HIV Viral Suppression Rates Show Increasing Trend, 1997 to 2015

HIV Viral Suppression Rates Show Increasing Trend, 1997 to 2015

Lower odds of having detectable viral load for older adults and those using ISTI-based regimen

The Nature of Stigma-Pain Relation in People Living With HIV

The Nature of Stigma-Pain Relation in People Living With HIV

Anxiety sensitivity may explain the association between stigma and pain among people living with HIV.

Trends in HIV/AIDS Have Worsened in African-Americans

Trends in HIV/AIDS Have Worsened in African-Americans

Recommendations have been developed for addressing the HIV/AIDS epidemic in the African-American community.

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab has antiviral activity among patients with multidrug resistant HIV-1 infection.

Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen

Tolerability of Switching to Long-acting Cabotegravir Plus Rilpivirine From Current HIV-1 Regimen

The ATLAS study enrolled 570 patients infected with HIV-1; participants were randomized to either the experimental or active comparator arms.

FDA Updates Labeling for Several HIV Medications to Include Interaction Data With DOACs

FDA Updates Labeling for Several HIV Medications to Include Interaction Data With DOACs

The FDA has approved labeling updates for Genvoya, Stribild and Tybost to include new drug-drug interaction data.

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

International Antiviral Society-USA Updates Recommendations for HIV Treatment and Prevention

The International Antiviral Society-USA Panel has updated its recommendations for the management and prevention of HIV infection, to reflect the most current data on new treatment regimens and strategies.

Previous Missed Appointments Predict Likelihood of Trend in Patients With HIV

Previous Missed Appointments Predict Likelihood of Trend in Patients With HIV

In a large, geographically diverse sample of patients engaged in routine HIV primary care, past HIV appointment attendance emerged as the most powerful predictor of future attendance.

Low HIV, Syphilis Screening Rates for Adolescents With Pelvic Inflammatory Disease

Low HIV, Syphilis Screening Rates for Adolescents With Pelvic Inflammatory Disease

New research found low and highly variable rates of HIV and syphilis screening among adolescents with pelvic inflammatory disease.

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Low Rates of Syphilis Testing in High-Risk Men Who Are HIV Positive

Close to one-third of sexually active HIV-positive men who have sex with men (MSM) have not received syphilis screening in the past 12 months.

Addressing Motivations That May Drive PrEP Appeal in MSM

Addressing Motivations That May Drive PrEP Appeal in MSM

A new theoretical model of understanding (PrEP) use intention in MSM highlights the complexity of decision-making about PrEP in MSM while providing insights into strategies for effective intervention.

Protease Inhibitors May Worsen Outcomes for Patients With HIV, Heart Failure

Protease Inhibitors May Worsen Outcomes for Patients With HIV, Heart Failure

Ritonavir-boosted protease inhibitor therapy is associated with worse outcomes, including death, in patients with HIV and heart failure.

Effects of Alcohol on Frontal White Matter in Individuals With HIV

Effects of Alcohol on Frontal White Matter in Individuals With HIV

Alcohol use may be associated with microstructural compromise to frontal white matter in patients infected with HIV who do not have dementia and are undergoing antiretroviral therapy.

Guidelines for ART Updated for Those With or at Risk for HIV

Guidelines for ART Updated for Those With or at Risk for HIV

ART recommended for almost all HIV-infected; should be initiated as soon as possible post diagnosis.

Juluca Maintains Viral Suppression in HIV Patients Through 100 Weeks

Juluca Maintains Viral Suppression in HIV Patients Through 100 Weeks

The SWORD 1 and SWORD 2 trials enrolled 1027 HIV-infected and virologically suppressed adults; both trials had an early (Day 1 to Week 52) and late (Week 52 to Week 148) switch phase.

New Data Reinforce Efficacy of Symtuza for HIV-1 Treatment

New Data Reinforce Efficacy of Symtuza for HIV-1 Treatment

In the new subgroup analysis, these results were found to be consistent regardless of baseline regimen.

Increased Use of Truvada for PrEP Linked to Declines in New HIV Cases

Increased Use of Truvada for PrEP Linked to Declines in New HIV Cases

Findings from the study were presented at the 22nd International AIDS Conference (AIDS 2018) in Amsterdam.

Healthcare Providers Unlikely to Initiate HIV Testing in High Risk Heterosexual Individuals

Healthcare Providers Unlikely to Initiate HIV Testing in High Risk Heterosexual Individuals

Despite CDC recommendations, about half of all heterosexual adults who are at increased risk for HIV infection and who received health care during a 12-month period were not offered HIV testing, and men were significantly less likely to be offered testing compared with women.

Few HIV Tests Given to Black Men Who Have Sex With Men in South

Few HIV Tests Given to Black Men Who Have Sex With Men in South

New HIV tests in the southern US are provided for black MSM even though they account for a substantial percentage of new diagnoses.

Ten Questions Screen Helps ID Disability in HIV+ Children

Ten Questions Screen Helps ID Disability in HIV+ Children

The Ten Questions (TQ) screen is an effective way to screen HIV-positive children for neurodevelopmental problems in resource-poor areas.

Etravirine Indication Expanded to Include Younger HIV Patients

Etravirine Indication Expanded to Include Younger HIV Patients

The approval of Intelence for this patient population was based on an open-label, single arm trial (N=20) which showed that the safety and efficacy of etravirine + an optimized background regimen (ritonavir-boosted protease inhibitor in combination with 1 or 2 NRTIs [N=14] and/or combination with an integrase inhibitor [N=7]) was comparable to that observed in adults.

FDA Approves First Darunavir-Based Single-Tablet Regimen for HIV-1 Infection

FDA Approves First Darunavir-Based Single-Tablet Regimen for HIV-1 Infection

The FDA has approved Symtuza for the treatment of HIV-1 infection in treatment-naive and in virologically suppressed adults.

Fixed-Dose Bictegravir Regimen: A Safe Alternative in Adults With HIV-1

Fixed-Dose Bictegravir Regimen: A Safe Alternative in Adults With HIV-1

Fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide might be a safe and efficacious alternative to continued boosted protease inhibitor therapy in patients with HIV-1

Mosaic HIV-1 Vaccine Induces Responses in Humans and Monkeys

Mosaic HIV-1 Vaccine Induces Responses in Humans and Monkeys

Mosaic adenovirus serotype 26-based vaccine induces immune responses in humans, rhesus monkeys

Fixed-Dose Bictegravir, Emtricitabine, Tenofovir Alafenamide Is Efficacious HIV-1 Treatment Option

Fixed-Dose Bictegravir, Emtricitabine, Tenofovir Alafenamide Is Efficacious HIV-1 Treatment Option

The fixed-dose combination of bictegravir, emtricitabine, and tenofovir alafenamide might provide a safe and efficacious option for ongoing treatment of HIV-1 infection

Shared Concerns Regarding Living Organ Donation in HIV

Shared Concerns Regarding Living Organ Donation in HIV

Concerns and motivations regarding living donor status in people with HIV should be assessed by physicians and independent living donor advocates.

Switch to Dolutegravir Regimen Improves Lipid Profile in HIV+ Patients

Switch to Dolutegravir Regimen Improves Lipid Profile in HIV+ Patients

Immediate and deferred switching from a boosted protease inhibitor to a dolutegravir regimen in HIV + patients is found to be highly efficacious.

Reduced-Dose Darunavir Effective in Virologically Suppressed HIV-1

Reduced-Dose Darunavir Effective in Virologically Suppressed HIV-1

A team of investigators sought to assess the safety and efficacy of a reduced dose of darunavir in well-suppressed, treatment-experienced individuals with HIV.

Increased Risk for Osteopenia, Osteoporosis in HIV Highlights Need for BMD Monitoring

Increased Risk for Osteopenia, Osteoporosis in HIV Highlights Need for BMD Monitoring

Investigators used DXA scans to assess the progression to osteopenia and osteoporosis in individuals with HIV.

Missed Opportunities for HIV Diagnosis Among Those at Risk

Missed Opportunities for HIV Diagnosis Among Those at Risk

Considerable numbers of MSM and persons who inject drugs who are unaware of their HIV infection report missed opportunities for diagnosis.

Efavirenz Not Assciated With Increased Depression Risk Compared With Nevirapine

Efavirenz Not Assciated With Increased Depression Risk Compared With Nevirapine

The researchers believe this study is the first to detect a statistically significant, unexpected inverse association between efavirenz use and depression.

Risk Prediction Scores Aid Management of Chronic Kidney Disease in HIV

Risk Prediction Scores Aid Management of Chronic Kidney Disease in HIV

Investigators sought to assess the effectiveness of tools to predict the risk of chronic kidney disease in individuals with HIV.

Assessment of Chronic Opioid Therapy in People Living With HIV

Assessment of Chronic Opioid Therapy in People Living With HIV

Appropriate monitoring and implementation of guidelines for opioid therapy is lacking in patients living with HIV.

Unplanned Pregnancies Prevalent Among HIV-Positive Women

Unplanned Pregnancies Prevalent Among HIV-Positive Women

Researchers examined unplanned pregnancies and contraceptive use among HIV-positive women in a cross-sectional study.

Multilevel Interventions Needed to Improve Barriers to PrEP

Multilevel Interventions Needed to Improve Barriers to PrEP

The final review included 47 articles that fell under 1 of the following categories: primary data on cognitive variables of providers; data on cognitive variables and perspectives of individuals at risk for HIV infection; literature on PrEP implementation; and case studies of PrEP demonstration and implementation projects.

Higher Rate of Mother-to-Child Transmission Among Women With Perinatal HIV

Higher Rate of Mother-to-Child Transmission Among Women With Perinatal HIV

Although rates of mother-to-child transmission of HIV have decreased as a result of effective treatments and protective delivery and feeding practices, transmission does persist.

Social Network Support Decreases Risk for HIV Seroconversion in Black MSM

Social Network Support Decreases Risk for HIV Seroconversion in Black MSM

The increased presence of social network support may decrease the risk for HIV seroconversion in black MSM.

Long-Term Viral Suppression May Decrease Cancer Risk in HIV+ Individuals

Long-Term Viral Suppression May Decrease Cancer Risk in HIV+ Individuals

Antiretroviral therapy resulting in long-term viral suppression of HIV may contribute to cancer prevention.

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

ART Simplification Does Not Affect Systemic Inflammation in Virologically Suppressed HIV

Simplification to atazanavir/ritonavir plus lamivudine as a maintenance therapy has the same effect on markers of systemic inflammation biomarkers as triple therapy.

HIV Pre-Exposure Prophylaxis Linked to Drop in Condom Use

HIV Pre-Exposure Prophylaxis Linked to Drop in Condom Use

For gay and bisexual men, an increase in HIV PrEP is associated with a reduction in condom use.

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

Closer Monitoring Recommended for Older Patients Treated With Dolutegravir for HIV

The maximum concentration of the integrase inhibitor dolutegravir was significantly higher in older people living with HIV.

Prezcobix Not Recommended During Pregnancy, According to Updated Labeling

Prezcobix Not Recommended During Pregnancy, According to Updated Labeling

The labeling now states that Prezcobix is not recommended for use in pregnant women due to substantially lower exposures of the active ingredients, darunavir and cobicistat, during pregnancy.

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

Cumulative Ritonavir-Boosted Darunavir Use May Be Associated With Increased CVD Risk

An increased risk for cardiovascular disease with ritonavir-boosted darunavir regimens for HIV was identified in a prospective multicenter study.

Cancer Treatment Disparities in Elderly HIV-Infected Americans Warrant Attention

Cancer Treatment Disparities in Elderly HIV-Infected Americans Warrant Attention

Cancer treatment rates for HIV-infected seniors were lowest among the younger subset of patients, who would likely benefit most from treatment in terms of life expectancy.

HIV Viral Suppression Rates in Psychiatric Inpatients With Comorbid Substance Use Disorders

HIV Viral Suppression Rates in Psychiatric Inpatients With Comorbid Substance Use Disorders

A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.

Bilirubin Levels May Be Predictive of Cardiovascular Disease in HIV

Bilirubin Levels May Be Predictive of Cardiovascular Disease in HIV

Bilirubin appeared to be inversely associated with cardiovascular disease in individuals with HIV enrolled in the Veterans Aging Cohort Study.

Continuous Medicaid Coverage Essential for People Living With HIV

Continuous Medicaid Coverage Essential for People Living With HIV

Implementing initiatives to maintain Medicaid enrollment and to expedite Medicaid reenrollment and having alternate resources available in gaps are important to ensure continuous antiretroviral therapy to optimize HIV outcomes.

COPD Frequently Misdiagnosed, Undiagnosed in Individuals Infected With HIV

COPD Frequently Misdiagnosed, Undiagnosed in Individuals Infected With HIV

In this study, researchers examined the appropriateness of diagnosis and treatment of chronic obstructive pulmonary disease in individuals with and without HIV.

HIV Self-Testing Increases Testing Frequency in High-Risk MSM

HIV Self-Testing Increases Testing Frequency in High-Risk MSM

Research is needed to understand how to prioritize supplementation and reach new testers, to educate men about the limitations of the current self-test, and to invest in the development and evaluation of self-tests able to detect early infection.

Short Cycle ART Noninferior to Continuous Therapy in Youth With HIV

Short Cycle ART Noninferior to Continuous Therapy in Youth With HIV

Standard-dose efavirenz-based short cycle therapy is a viable option for virologically suppressed HIV-1-infected young people receiving first-line antiretroviral therapy with 3-monthly viral load monitoring.

FDA: Possible Risk of Neural Tube Birth Defects With Certain Antiretroviral Agents

FDA: Possible Risk of Neural Tube Birth Defects With Certain Antiretroviral Agents

The FDA has received reports of serious neural tube birth defects in babies born to women who received dolutegravir for HIV.

Increasing Incidence of Syphilis in People With HIV

Increasing Incidence of Syphilis in People With HIV

Steady increases in the syphilis incidence rate occurred through 2015, particularly among people with HIV who are younger, non-Hispanic/Latino, and are men who have sex with men.

Truvada Approved for HIV-1 Pre-Exposure Prophylaxis in At-Risk Adolescents

Truvada Approved for HIV-1 Pre-Exposure Prophylaxis in At-Risk Adolescents

The use of Truvada for PrEP in the adolescent population was based on a single-arm, open-label clinical study (ATN113) among 67 HIV-1 negative young men (aged 15 to 17 years) who have sex with men (YMSM).

FDA Approves Epoetin Alfa Biosimilar Retacrit

FDA Approves Epoetin Alfa Biosimilar Retacrit

The approval of Retacrit was based on a review of evidence that included human pharmacokinetic/pharmacodynamic data and clinical immunogenicity data which demonstrated a high degree of similarity between Retacrit and its reference product.

PD-1 Inhibitors Safe, Effective in Patients With HIV and Non-Small Cell Lung Cancer

PD-1 Inhibitors Safe, Effective in Patients With HIV and Non-Small Cell Lung Cancer

Nivolumab and pembrolizumab can be safe and effective for patients with NSCLC and HIV.

Cancer Incidences and Burden Expected to Shift in HIV

Cancer Incidences and Burden Expected to Shift in HIV

The cancer burden among persons living with HIV is projected to shift by 2030.

Sign Up for Free e-newsletters